Trial intelligence / Profile preview

Safety of Oral O1/O139 Cholera Vaccine Phase I

NCT03237663Phase 1Completed

Sponsor
Jiangsu Provincial Center for Disease Control and Prevention
Start
Mar 2015
Primary completion
Nov 2016
Modality
Vaccines & Immunotherapeutics
01

Overview

Phase 1, open-label trial in cholera (2 arms), sponsored by Jiangsu Provincial Center for Disease Control and Prevention. Primary endpoint: Proportion of subjects reporting solicited adverse reactions. Started Mar 2015; status: completed.

02

Conditions

cholera

Beyond the preview

Go deeper on NCT03237663.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03237663.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call